Surface Oncology competitive analysis

Latest publications and patents of Surface Oncology New

Explore the latest publications and patents granted to Surface Oncology, showcasing their recent innovations and technological advancements.

Explore patent oppositions filed by Surface Oncology against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

Antibodies Against Human Cd39 And Use Thereof For Inhibiting T Regulatory Cells ActivityINSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALEJun 21, 2021
Anti-Pvrig Antibodies And Methods Of UseCOMPUGENOct 28, 2020

Latest PTAB cases involving Surface Oncology

Discover the latest PTAB cases involving Surface Oncology, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Surface Oncology with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
SURFACE ONCOLOGY2 - - - Highly Aggressive
COMPUGEN - 5 - - Non-Active
INSERM INSTITUT NATIONAL DE LA SANT ET DE LA RECHERCHE MDICALE - 35 - - Non-Active